Samsung Bioepis posts sales of US$545m in Europe in 2018 - The Investor

Samsung Bioepis posts sales of US$545m in Europe in 2018  The Investor

Korean pharmaceutical firm Samsung Bioepis saw its accumulated sales in the European market hit US$545.2 million last year, data showed on Jan. 30.